These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 1889734)

  • 21. The relationship between vascular headaches and low-dose oral contraceptives.
    Karsay K
    Ther Hung; 1990; 38(4):181-5. PubMed ID: 2094059
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Oral contraception using the "weekbypill" Depositon].
    Göretzlehner G; Rudolf K; Klausch B
    Zentralbl Gynakol; 1974 Dec; 96(50):1569-76. PubMed ID: 4456907
    [No Abstract]   [Full Text] [Related]  

  • 23. [Combined oral contraceptives with extremely low doses of estrogen (15 micrograms in a single tablet)].
    Cepický P; Dvorák K; Holub Z; Uzel R
    Ceska Gynekol; 2001 Jul; 66(4):297-9. PubMed ID: 11569429
    [No Abstract]   [Full Text] [Related]  

  • 24. Oral contraceptives according to the normophasic principle.
    Borglin NE; Klottrup P
    Arzneimittelforschung; 1978; 28(12):2354-7. PubMed ID: 582954
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum folate and Vitamin B12 levels in women using modern oral contraceptives (OC) containing 20 microg ethinyl estradiol.
    Andrès E; Noel E
    Eur J Obstet Gynecol Reprod Biol; 2004 Aug; 115(2):241-2. PubMed ID: 15262367
    [No Abstract]   [Full Text] [Related]  

  • 26. [Lindynette 20].
    Peichinova I
    Akush Ginekol (Sofiia); 2008; 47 Suppl 2():59-60. PubMed ID: 19496455
    [No Abstract]   [Full Text] [Related]  

  • 27. Examination of the potential interaction between ketoconazole (Nizoral) and oral contraceptives with special regard to products of low hormone content (Rigevidon, anteovin).
    Kovács I; Somos P; Hámori M
    Ther Hung; 1986; 34(3):167-70. PubMed ID: 3441880
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effects of oral estrogen-progestin contraceptives on blood coagulation and assessment of the risk of thromboembolism].
    Surico N; Porcelli A; Petrelli P; Amedeo M; Crivello T; Ferraris G
    Minerva Ginecol; 1988 Sep; 40(9):559-62. PubMed ID: 2975773
    [No Abstract]   [Full Text] [Related]  

  • 29. [Kallikrein concentration in mixed saliva after contraceptive administration or postmenopausal hormone replacement].
    Meyer P; Werner E; Polzin A
    Laryngorhinootologie; 1998 Sep; 77(9):521-4. PubMed ID: 9795931
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Carpal tunnel syndrome caused by oral contraceptives].
    Tordesillas Lia C; Rodríguez de la Serna A; Pradas Orozco J; Illa Sendra I
    Rev Clin Esp; 1985 Jun; 177(1):46. PubMed ID: 4035041
    [No Abstract]   [Full Text] [Related]  

  • 31. Continuous oral contraceptives: are bleeding patterns dependent on the hormones given?
    Edelman AB; Koontz SL; Nichols MD; Jensen JT
    Obstet Gynecol; 2006 Mar; 107(3):657-65. PubMed ID: 16507938
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in plasma HDL-cholesterol in women using oral contraceptives in Kenya.
    Maina FW; Sekadde-Kigondu CB; Ojwang PJ; Mati JK
    East Afr Med J; 1987 Jul; 64(7):442-7. PubMed ID: 3691360
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prescribing an oral contraceptive for the individual woman.
    Chick P
    Aust Fam Physician; 1980 Feb; Suppl():8-12. PubMed ID: 6444808
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Intrahepatic cholestasis caused by oral contraceptives with early onset].
    Mur M; Guerrero L
    Rev Esp Enferm Apar Dig; 1988 May; 73(5 Pt 1):528-9. PubMed ID: 3406494
    [No Abstract]   [Full Text] [Related]  

  • 35. [Side effects of oral contraceptives in internal medicine--a current problem].
    Piper C; Mathias B; Hopf G
    Verh Dtsch Ges Inn Med; 1989; 95():706-12. PubMed ID: 2603507
    [No Abstract]   [Full Text] [Related]  

  • 36. Use of an oral contraceptive containing drospirenone in an extended regimen.
    Sillem M; Schneidereit R; Heithecker R; Mueck AO
    Eur J Contracept Reprod Health Care; 2003 Sep; 8(3):162-9. PubMed ID: 14667328
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Response to a letter to the editors by Prof. M. Mall, PD Dr. I. Werner-Zodrof and PD Dr. P. Huber (Geburtsh. u. Frauenheilk. 51 (1991) 1014].
    Kuhl H
    Geburtshilfe Frauenheilkd; 1992 Jul; 52(7):445-6. PubMed ID: 1499958
    [No Abstract]   [Full Text] [Related]  

  • 38. Pharmacokinetics of ethinylestradiol and levonorgestrel after administration of two oral contraceptive preparations.
    Carol W; Klinger G; Jäger R; Kasch R; Brandstädt A
    Exp Clin Endocrinol; 1992; 99(1):12-7. PubMed ID: 1628691
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects on coagulation of levonorgestrel- and desogestrel-containing low dose oral contraceptives: a cross-over study.
    Middeldorp S; Meijers JC; van den Ende AE; van Enk A; Bouma BN; Tans G; Rosing J; Prins MH; Büller HR
    Thromb Haemost; 2000 Jul; 84(1):4-8. PubMed ID: 10928461
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [What does the micropill bring?].
    Mall-Haefeli M
    Ther Umsch; 1986 May; 43(5):365-71. PubMed ID: 2941889
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.